OTC · Financial Statements
CannaPharmaRX, Inc. (CPMD) Financial Statements
$0.00
OTC: CPMD
Market Cap $1.42M
Overview Financials Dividend CannaPharmaRX, Inc. most recently reported annual revenue of $1.0M, a net loss of $11.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $1.0M $1.0M Operating Profit $-3.0M $-5.0M $-2.0M $-4.0M $-3.0M Net Profit $-9.0M $-9.0M $4.0M $-10.0M $-11.0M EPS $-0.12 $-0.04 $0.01 $-0.02 $-0.02 Op Margin — — — -439.7% -245.8%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $0 $5.0M $12.0M $11.0M $7.0M Total Liabilities $13.0M $23.0M $24.0M $31.0M $37.0M Cash $0 $0 $0 $0 $0 Borrowings $9.0M $15.0M $13.0M $14.0M $21.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-2.0M $-1.0M $-2.0M $-2.0M $-1.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $1.0M $1.0M $2.0M $0 $0 Net Cash Flow $0 $0 $0 $0 $0 Free Cash Flow $-2.0M $-2.0M $-2.0M $-2.0M $-1.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -2.72 FCF Yield -30.66% Quick Ratio 0.00 Interest Coverage -1.38 Return 1Y -30.00% Return 3Y -85.00% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .